Llibre, Josep M.; Bravo, Isabel; Ornelas, Arelly; Santos, José R.; Puig, Jordi; Martín Iguacel, Raquel; Paredes, Roger; Clotet, Bonaventura
(Plos One, 2015)
Background
Switching subjects with persistently undetectable HIV-1 viremia under antiretroviral treatment
(ART) to once-daily tenofovir/emtricitabine (or lamivudine) + nevirapine is a cost-effective
and well-tolerated ...